BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32247279)

  • 21. "T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach".
    Tirado CA; Starshak P; Delgado P; Rao N
    Exp Hematol Oncol; 2012 Aug; 1(1):21. PubMed ID: 23211026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia.
    Patil P; Cieslak A; Bernhart SH; Toprak UH; Wagener R; López C; Wiehle L; Bens S; Altmüller J; Franitza M; Scholz I; Jayne S; Ahearne MJ; Scheffold A; Jebaraj BMC; Schneider C; Costa D; Braun T; Schrader A; Campo E; Dyer MJS; Nürnberg P; Dürig J; Johansson P; Böttcher S; Schlesner M; Herling M; Stilgenbauer S; Macintyre E; Siebert R
    Genes Chromosomes Cancer; 2020 Apr; 59(4):261-267. PubMed ID: 31677197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell Prolymphocytic Leukemia.
    Sud A; Dearden C
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):273-283. PubMed ID: 28340878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.
    Thick J; Metcalfe JA; Mak YF; Beatty D; Minegishi M; Dyer MJ; Lucas G; Taylor AM
    Oncogene; 1996 Jan; 12(2):379-86. PubMed ID: 8570215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proto-oncogene TCL1: more than just a coactivator for Akt.
    Noguchi M; Ropars V; Roumestand C; Suizu F
    FASEB J; 2007 Aug; 21(10):2273-84. PubMed ID: 17360849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
    Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X
    Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting mature T cell leukemia: new understanding of molecular pathways.
    Pekarsky Y; Hallas C; Croce CM
    Am J Pharmacogenomics; 2003; 3(1):31-6. PubMed ID: 12562214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.
    Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A
    Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
    Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Where do we currently stand with T-cell prolymphocytic leukemia?
    Khot A
    Leuk Lymphoma; 2019 Mar; 60(3):563-565. PubMed ID: 30668215
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
    Chen X; Cherian S
    Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia.
    Soulier J; Pierron G; Vecchione D; Garand R; Brizard F; Sigaux F; Stern MH; Aurias A
    Genes Chromosomes Cancer; 2001 Jul; 31(3):248-54. PubMed ID: 11391795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
    Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
    Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.
    López C; Bergmann AK; Paul U; Murga Penas EM; Nagel I; Betts MJ; Johansson P; Ritgen M; Baumann T; Aymerich M; Jayne S; Russell RB; Campo E; Dyer MJ; Dürig J; Siebert R
    Br J Haematol; 2016 Apr; 173(2):265-73. PubMed ID: 26917488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
    Bresin A; Ragone G; Cristofoletti C; Arcelli D; Bassi C; Caprini E; Fiorenza MT; Helmer Citterich M; Russo G; Narducci MG
    PLoS One; 2018; 13(10):e0204775. PubMed ID: 30286151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.
    Herling M; Teitell MA; Shen RR; Medeiros LJ; Jones D
    Blood; 2003 Jun; 101(12):5007-9. PubMed ID: 12576313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protooncogene TCL1 is an Akt kinase coactivator.
    Laine J; Künstle G; Obata T; Sha M; Noguchi M
    Mol Cell; 2000 Aug; 6(2):395-407. PubMed ID: 10983986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances and Perspectives in the Treatment of T-PLL.
    Braun T; von Jan J; Wahnschaffe L; Herling M
    Curr Hematol Malig Rep; 2020 Apr; 15(2):113-124. PubMed ID: 32034661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
    Hu Z; Medeiros LJ; Xu M; Yuan J; Peker D; Shao L; Tang Z; Mai B; Thakral B; Rios A; Hu S; Wang W
    Am J Clin Pathol; 2023 Apr; 159(4):325-336. PubMed ID: 36883805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.
    Andersson EI; Pützer S; Yadav B; Dufva O; Khan S; He L; Sellner L; Schrader A; Crispatzu G; Oleś M; Zhang H; Adnan-Awad S; Lagström S; Bellanger D; Mpindi JP; Eldfors S; Pemovska T; Pietarinen P; Lauhio A; Tomska K; Cuesta-Mateos C; Faber E; Koschmieder S; Brümmendorf TH; Kytölä S; Savolainen ER; Siitonen T; Ellonen P; Kallioniemi O; Wennerberg K; Ding W; Stern MH; Huber W; Anders S; Tang J; Aittokallio T; Zenz T; Herling M; Mustjoki S
    Leukemia; 2018 Mar; 32(3):774-787. PubMed ID: 28804127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.